Table 2.
Kaplan–Meier survival analysis.
| Deaths Censored | |||||
|---|---|---|---|---|---|
| n | n | n | Mean survival days at June in 2003 (SE) | 95% CI | |
| Lung | |||||
| Urgent referrals | 81 | 39 | 42 | 458.2 (37.9) | 383.9 to 532.5 |
| Diagnosed through other routes | 222 | 76 | 146 | 591.9 (55.1) | 543.7 to 640.2 |
| Colorectal | |||||
| Urgent guideline referrals | 48 | 13 | 35 | 609.5 (46.0) | 519.4 to 699.6 |
| Diagnosed through other routes | 168 | 55 | 113 | 720.3 (36.2) | 649.3 to 791.3 |
| Prostate | |||||
| Urgent guideline referrals | 45 | 1 | 44 | 755.7 (15.1) | 726.1 to 785.3 |
| Diagnosed through other routes | 91 | 3 | 88 | 808.8 (14.8) | 779.8 to 837.9 |
| Ovarian | |||||
| Urgent guideline referrals | 11 | 5 | 6 | 459.9 (110.4) | 243.6 to 676.4 |
| Diagnosed through other routes | 47 | 16 | 31 | 685.7 (63.9) | 560.5 to 810.8 |
SE = standard error.